Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silviu Sbiera

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Plos One|September 26, 2013
Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?Cristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Hormones & Cancer|October 18, 2015
Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsDorothee Heck, Sebastian Wortmann, Luitgard Kraus, et al.
Frontiers in Endocrinology|December 27, 2021
Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic ImplicationsIuliu Sbiera, Stefan Kircher, Barbara Altieri, et al.
Cancers|March 25, 2020
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical CancerMaurine Oreglia, Silviu Sbiera, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|October 12, 2012
Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosisCristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Molecular and Cellular Endocrinology|March 23, 2016
The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid compositionHolger A Scheidt, Ivan Haralampiev, Stephan Theisgen, et al.
Journal for Immunotherapy of Cancer|June 1, 2020
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinomaLaura-Sophie Landwehr, Barbara Altieri, Jochen Schreiner, et al.
Redox Biology|December 18, 2025
FOS and JUN regulate oxidative stress and steroidogenesis in human aldosterone-producing adenomasJia Wei, Eleonora Duregon, Mauro G Papotti, et al.
Endocrinology|January 8, 2019
Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing SyndromeKerstin Bathon, Isabel Weigand, Jens T Vanselow, et al.
European Journal of Endocrinology|April 8, 2021
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burdenLaura-Sophie Landwehr, Jochen Schreiner, Silke Appenzeller, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Plos One|September 26, 2013
Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?Cristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Hormones & Cancer|October 18, 2015
Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsDorothee Heck, Sebastian Wortmann, Luitgard Kraus, et al.
Frontiers in Endocrinology|December 27, 2021
Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic ImplicationsIuliu Sbiera, Stefan Kircher, Barbara Altieri, et al.
Cancers|March 25, 2020
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical CancerMaurine Oreglia, Silviu Sbiera, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|October 12, 2012
Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosisCristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Molecular and Cellular Endocrinology|March 23, 2016
The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid compositionHolger A Scheidt, Ivan Haralampiev, Stephan Theisgen, et al.
Journal for Immunotherapy of Cancer|June 1, 2020
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinomaLaura-Sophie Landwehr, Barbara Altieri, Jochen Schreiner, et al.
Redox Biology|December 18, 2025
FOS and JUN regulate oxidative stress and steroidogenesis in human aldosterone-producing adenomasJia Wei, Eleonora Duregon, Mauro G Papotti, et al.
Endocrinology|January 8, 2019
Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing SyndromeKerstin Bathon, Isabel Weigand, Jens T Vanselow, et al.
European Journal of Endocrinology|April 8, 2021
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burdenLaura-Sophie Landwehr, Jochen Schreiner, Silke Appenzeller, et al.
Pageof 8